Psidium cattleianumfruit extract prevents systemic alterations in an animal model of type 2 diabetes mellitus: comparison with metformin effects

Autor: Cardoso, Juliane De Souza, Cardoso Teixeira, Fernanda, De Mello, Julia Eisenhardt, Soares De Aguiar, Mayara Sandrielly, Souto Oliveira, Pathise, Torchelsen Saraiva, Juliane, Vizzotto, Marcia, Borelli Grecco, Fabiane, Lencina, Claiton Leoneti, Spanevello, Roselia Maria, Tavares, Rejane Giacomelli, Stefanello, Francieli Moro
Zdroj: Biomarkers; February 2023, Vol. 28 Issue: 2 p238-248, 11p
Abstrakt: AbstractObjective:In this study, we aimed to determine the role of Psidium cattleianumextract (PCE) and compare its effects with those of metformin (Met) in an animal model with type 2 diabetes mellitus (T2DM).Methods:T2DM was induced in rats using a high-fat diet (HFD), followed by a single dose of streptozotocin (STZ). Met and PCE were administered intragastrically once a day throughout the experiment, and their effects on biochemical, inflammatory, oxidative, and histological parameters were evaluated.Results:Met and PCE prevented the increase in serum levels of glucose, total cholesterol (TC), triacylglycerol (TG), very low-density lipoprotein (VLDL) and interleukin-6 (IL-6) induced by T2DM, and restored redox homeostasis in the liver and brain. Met increased the serum levels of anti-inflammatory cytokine and interleukin-10 (IL-10). Furthermore, both treatments restored the liver and pancreas from marked cellular disorganisation, vacuolisation, and necrosis, with PCE being more effective than Met in recovering histological changes.Conclusion:PCE is a promising agent for the prevention of T2DM complications.
Databáze: Supplemental Index